ImmunoPET helps predicting the efficacy of antibody-drug conjugates targeting TENB2 and STEAP1.
Williams SP, Ogasawara A, Tinianow JN, Flores JE, Kan D, Lau J, Go M, Vanderbilt AN, Gill HS, Miao L, Goldsmith J, Rubinfeld B, Mao W, Firestein R, Yu SF, Marik J, Terwisscha van Scheltinga AG.
Williams SP, et al. Among authors: rubinfeld b.
Oncotarget. 2016 May 3;7(18):25103-12. doi: 10.18632/oncotarget.8390.
Oncotarget. 2016.
PMID: 27029064
Free PMC article.